The Effect of an Auditory Rhythmic Cue on the Frequency of Rolling in Patients with Dysphagia and Parkinson's Disease
Launched by HOPITAL LA MUSSE · Nov 18, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using rhythmic sounds can help patients with Parkinson’s disease who have difficulty swallowing, a condition known as dysphagia. The researchers want to find out if these rhythmic auditory cues can reduce a specific swallowing problem called "rolling," which happens when food or liquid doesn't move smoothly down the throat. Over the course of 7 weeks, participants will attend three therapy sessions a week at La Musse hospital, where a speech therapist will guide them through exercises while assessing their swallowing ability before, after, and three months later.
To be eligible for this study, participants must be at least 18 years old, diagnosed with idiopathic Parkinson’s disease, and have a swallowing disorder characterized by rolling. However, individuals with severe swallowing difficulties or cognitive impairments, among other specific conditions, may not qualify. If you or a loved one is interested, you can expect to undergo several assessments to monitor progress and receive personalized support during the rehabilitation sessions. This trial aims to help improve the swallowing experience for those affected by Parkinson’s disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of idiopathic Parkinson's disease established by a neurologist using a DAT SCAN and clinical examination;
- • Presence of a swallowing disorder, specifically rolling;
- • Patient affiliated with the social security system;
- • Patient aged 18 years or older
- Exclusion Criteria:
- • Severe pharyngeal dysphagia (leading to aspiration with nectar and pudding textures);
- • Severe cognitive impairment (score \<24 on the Mini Mental Parkinson test);
- • Known deafness/profound hearing loss;
- • Patients under legal protection measures;
- • History of reconstructive ENT surgery at the oropharyngeal level;
- • Neurological history that could cause a swallowing disorder (e.g., stroke);
- • Patient with a gastrostomy and no oral feeding;
- • Ongoing speech therapy for swallowing;
- • The patient is included in another research protocol;
- • Pregnant women or women suspected of being pregnant;
About Hopital La Musse
Hopital La Musse is a leading healthcare institution renowned for its commitment to advancing medical research and patient care. With a focus on innovative clinical trials, the hospital integrates cutting-edge technology and best practices to explore new treatment options across various therapeutic areas. Its multidisciplinary team of experienced researchers and healthcare professionals collaborates closely to ensure the highest standards of ethical conduct and patient safety. By fostering a culture of scientific inquiry and collaboration, Hopital La Musse aims to contribute significantly to the body of medical knowledge and improve health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Sébastien De Morsent, Normandie, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported